DPA
NVO

Delphi Private Advisors’s Novo Nordisk NVO Stock Holding History

Delphi Private Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$7K Buy
+260
New +$6.43K 0.04% 41

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Delphi Private Advisors's NVO Position: Q2 2019 in Review

Delphi Private Advisors opened a new position in Novo Nordisk (NVO) in Q2 2019: 260 shares worth $7K. The stake represents 0.04% of the portfolio and ranks #41 among its holdings.

559 funds tracked by Wall St. Rank hold NVO as of Q2 2019.

  • Delphi Private Advisors held 260 shares of Novo Nordisk worth $7K as of Q2 2019.
  • Novo Nordisk was a new Delphi Private Advisors position in Q2 2019.
  • Novo Nordisk made up 0.04% of Delphi Private Advisors's portfolio in Q2 2019, its #41 holding.
  • 559 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2019.

Based on Delphi Private Advisors's 13F filing for Q2 2019, filed 17 Jul 2019.